Please login to the form below

commercialisation

This page shows the latest commercialisation news and features for those working in and with pharma, biotech and healthcare.

In 2019, Sandoz and Polpharma Biologics entered into a global commercialisation agreement for the biosimilar.

Takeda announces CHMP recommendation for Adcetris in Hodgkin lymphoma

Under the terms of the collaboration agreement, Seagen has US and Canadian commercialisation rights, while Takeda has rights to commercialise Adcetris in the rest of the world.
Almirall receives CHMP recommendation for lebrikizumab in atopic dermatitis

development and commercialisation of the drug in the US and the rest of the world.
Moderna and Immatics announce oncology collaboration worth over $1.7bn

Moderna will lead the development and commercialisation of the cancer vaccines resulting from the collaboration, while Immatics will be responsible for pre-clinical and potential early-stage studies for the IMA203
AstraZeneca’s rare disease unit partners with Verge Genomics in deal worth over $840m

Alexion will select high-potential targets for each indication and will have the option to licence and advance successful targets through clinical development and commercialisation.
Seagen and Nurix announce oncology partnership worth over $3.4bn

Seagen will conjugate these degraders to antibodies to make a new class of medicines called degrader-antibody conjugates (DACs) and advance DAC drug candidates through preclinical and clinical development and commercialisation.

More from news
Approximately 0 fully matching, plus 638 partially matching documents found.

Powering creativity to work in harmony with science and data

towards real-world evidence and patient input from R&D through clinical trials to commercialisation.
Adopting a holistic approach in crafting a product’s value story: utilising HEOR and RWE throughout the product life cycle

The strong HE and RWE foundation built in the early phases will result in efficiencies in understanding and communicating value as your product moves toward commercialisation.
Cross-functional alignment

From marketing to medical affairs, from market access to regulatory, from sales to government affairs, commercialisation in our industry is not just a team game, it needs teams of many diverse
CAR-T cell therapy in oncology

commercialisation. One of the primary reasons for this complexity is their personalisation.
The future of medtech is in the past

Our domestic medtech industry was conspicuous by its determination to pick up the COVID-19 ball and run with it, meeting the twin challenges of innovation and commercialisation head-on.

More from intelligence
Approximately 2 fully matching, plus 142 partially matching documents found.

Ashfield appoints new UK head of patient solutions

Stephanie Hill strengthens the commercial team at leading healthcare network. Ashfield, a leader in commercialisation services for the healthcare industry, has appointed Stephanie Hill (pictured above) as its new head of
Health comms agency emotive hires new cell and gene therapy leader

Dr Germano Ferrari. His most recent role was as a programme manager at the UK’s Cell and Gene Therapy Catapult where he helped develop commercialisation pathways for several pre-clinical
New hires at Ferring, Flexion and Immunocore

Berman initially joined the biotech back in September last year with the aim to advance the company’s lead candidate IMCgp100 towards commercialisation. ... IMCgp100, towards commercialisation.”.
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

Her appointment will significantly strengthen Immunocore as we advance our lead candidate, IMCgp100, towards commercialisation, and our growing pipeline of TCR candidates through clinical development.”.
BMS appoints new commercial leader, Davies joins Eisai and more

His new role builds on his career history surrounding drug development through to commercialisation in both pharma and biotech industries.

More from appointments
Approximately 0 fully matching, plus 122 partially matching documents found.

Mtech Access

We work in expert-led partnerships with innovators across the healthcare sector providing commercialisation strategy, evidence synthesis and analysis, and value demonstration services, supporting the journey from R&D to market.
ICS/ICB leaders Penny Dash and Paul Miller announced as speakers for the NHS Transformation Symposium

Each year, Mtech Access invite UK market access and commercialisation teams from Pharma and MedTech companies to join guest speakers from across the NHS at their NHS Symposium. ... As market access specialists, they work in expert-led partnerships with
Article: War in the Blood - The battle takes shape in the burgeoning European oncology CAR-T market access space

With the continuing evolution of the CAR-T landscape, Research Partnership speaks to payers across Europe to investigate the market access and commercialisation potential for manufacturers of these exciting, in theory,
Origins Insights Offering Explained

the patient voice is included from drug discovery to commercialisation.
Introduction to Origins

Origins is passionate about ensuring the patient voice is front of mind; assisting our clients to meet the regulatory requirements for patient focused drug development from discovery to commercialisation and beyond.

More from PMHub
Approximately 5 fully matching, plus 49 partially matching documents found.

No results were found

Add my company

We are a leading provider of outsourced commercial, medical and recruitment services to UK pharmaceutical, biotech and healthcare companies....

The importance of accelerating clinical trial diversity: Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications: There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day: At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....

Email:
Password: